International market access & pricing for innovative medicines

With US-based companies focused on securing access in North America, understanding the international payer landscape and expectations early on is key. Reflecting the need to obtain expert input in time to influence the statistical analysis plan, early senior advisor from key markets plays an important role. An effective mix of individual and group meetings, combined with effective use of technology, yielded highly credible and relevant insights that shaped the international market access strategy. The second step included interactions with payer authorities and allowed to confirm the perception of the therapy area, as well as the specific information needs. Supporting the company’s internal capabilities, we augmented the network and knowledge to enable a nimble and lean organization to shape the internal and external decisions.